Symposium - European Medical Journal

Continue

Symposiums

Hematology
13 Mins
18 Mar 2022

The Future of Gene Therapy for Haemophilia A and B: Innovative Treatment Management Strategies, Perspectives, and Updated Trial Results

Monogenic diseases such as haemophilia A and B are inherited conditions arising from mutations in a single gene. One defective gene leads…
Nephrology
11 Mins
17 Mar 2022

Improving Outcomes for Haemodialysis Patients: Sizing Up the Problem – Interviews with Two Key Opinion Leaders

Despite recent developments in renal medicine, mortality rates remain high in patients receiving long-term haemodialysis (HD) due to…
EMJ Oncology 10 [Supplement 5] 2022 Feature Image
Oncology
8 Mins
7 Mar 2022

Implementation of MET Molecular Testing in the Clinic: Latest Evidence for Mesenchymal–Epithelial Transition Inhibitors in Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a heterogeneous disease with many genomic mutations. Furthermore, comprehensive genomic…
Dermatology
6 Mins
2 Mar 2022

Revolution in Photoprotection: How to Recommend and Adapt Photoprotection According to Skin Phototype and Dermatoses

The solar spectrum is composed of various wavelengths of electromagnetic radiation that can penetrate the skin to different levels: the longer…
EMJ Oncology 10 [Supplement 4] 2022 Feature Image
Oncology
7 Mins
24 Feb 2022

Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer

Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…
EMJ
Hematology
9 Mins
21 Feb 2022

The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight

Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…
Oncology
11 Mins
18 Feb 2022

New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders

CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…
Dermatology
5 Mins
3 Feb 2022

Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from the EADV 2021

The latest research on autoimmune skin disease has studied the efficacy and safety characterisation of guselkumab (GUS), a human monoclonal…
We’ve noticed you’re accessing
from North/South America.